These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4634907)

  • 1. [Lyophilization of thickening agents].
    Contreras P; Lladser M; Arancibia A
    Farmaco Prat; 1972 Oct; 27(10):552-63. PubMed ID: 4634907
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the evaluation of breaking substances in tablets].
    Modrzejewski F; Wochna L
    Pharmazie; 1966 Jun; 21(6):355-8. PubMed ID: 6000985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oxypropylmethylcellulose as a binding agent in tablet preparation].
    Borisenko IuB; Borzunov EE; Obukhova RI; Dekhtiarenko VM
    Farm Zh; 1969; 24(2):51-3. PubMed ID: 5793389
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of composition of pharmaceutic aids on the disintegration of tablets].
    Borzunov EE; Shevchenko SM
    Farmatsiia; 1969; 18(1):20-3. PubMed ID: 5770765
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on gynaecological hydrophilic lactic acid preparations, Part 7: use of chitosan as lactic acid carrier in intravaginal tablets (globuli vaginales).
    Małolepsza-Jarmołowska K
    Pharmazie; 2006 Sep; 61(9):780-2. PubMed ID: 17020155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carboxymethyldextran as pharmaceutic aid in tablets. II. Properties of tablets prepared by means of carboxymethyldextran].
    Chwialkowska L; Krówczyński L
    Acta Pol Pharm; 1968; 25(6):583-90. PubMed ID: 5730630
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of size on other physical properties of granules and their corresponding tablets.
    Marks AM; Sciarra JJ
    J Pharm Sci; 1968 Mar; 57(3):497-504. PubMed ID: 5655596
    [No Abstract]   [Full Text] [Related]  

  • 8. The preparation of controlled release particles in the sub-sieve size range.
    Seager H; Baker P
    J Pharm Pharmacol; 1972 Dec; 24():Suppl:123P-124. PubMed ID: 4144842
    [No Abstract]   [Full Text] [Related]  

  • 9. [Binding activity of some adjuvants and their influence on the physical properties of granules and tablets].
    Delonca MH; Joachim MJ; Munerot MJ; Freida MA
    Farmaco Prat; 1973; 28(1):3-25. PubMed ID: 4683656
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some galenic procedures used in the substitution therapy with Lactobacillus acidophilus].
    Gumma A; Mirimanoff A
    Pharm Acta Helv; 1971 May; 46(5):278-89. PubMed ID: 4997965
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carboxymethyldextran as a pharmaceutic aid in tablets. 3. Study of solubility rate of acetylsalicylic acid from tablets].
    Chwialkowska L; Krówczyński L
    Acta Pol Pharm; 1969; 26(1):45-50. PubMed ID: 5782220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carboxyvinyl polymers in pharmaceutical technology].
    Perotti AG
    Farmaco Prat; 1970 Nov; 25(11):651-88. PubMed ID: 5497424
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of polyvinylalcohol (PVA) in obtaining sugar-containing or sugar-free dragee coatings].
    Moldenhauer H; Kala H; Zessin G; Nauenburg G
    Pharmazie; 1974 Jan; 29(1):26-31. PubMed ID: 4362359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methylcellulose and its rheologic properties].
    Woźniak J
    Rocz Panstw Zakl Hig; 1972; 23(1):117-27. PubMed ID: 5031458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carboxymethyldextran as pharmaceutic aid in tablets. I. Properties of granulates obtained by means of sodium salt of carboxymethyldextran].
    Chwialkowska L; KRówczyński L
    Acta Pol Pharm; 1968; 25(6):577-81. PubMed ID: 5730629
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on gynaecological hydrophilic lactic acid preparations, part 6: use of Eudragit E-100 as lactic acid carrier in intravaginal tablets.
    Małolepsza-Jarmołowska K; Kubis AA; Hirnle L
    Pharmazie; 2003 May; 58(5):334-6. PubMed ID: 12779050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral lyophilizate--an alternative for products with low-soluble drugs.
    Gafiţeanu E; Drăgănoiu S; Cojocaru I
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):170-3. PubMed ID: 10756792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of burst substances in tablets].
    Hüttenrauch R; Jacob J
    Pharmazie; 1971 May; 26(5):293-8. PubMed ID: 5563062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.